… signaling and this way potentially prevent or mitigate Acute Respiratory Distress Syndrome
(ARDS) COVID-19 patients. Compared to the monoclonal antibodies, tocilizumab, sarilumab, …

… has been shown to be effective in patients with cytokine storm syndromes [Citation66],
and … for the treatment of cytokine release syndrome in patients with COVID-19 [Citation67]. …

… cytokine storms play an important role in severe COVID-19 … key inflammatory factors in
cytokine release syndrome (CRS) … critically ill COVID-19 patients with significantly elevated IL-6. …

… describe the neurological manifestations of patients with COVID-19 and to gain … COVID-19
symptom onset (D0). Red stars denote the days on which levels of cytokine release syndrome-…

… In COVID-19 patients with elevated inflammatory cytokines, postmortem pathology has
revealed tissue necrosis and interstitial macrophage and monocyte infiltrations in the lung, heart …

… According to the results of monitoring (the date of transfer out of the ICU), the final follow-up
date was 18 February 2020 for all COVID-19 patients participating in this study. Study of this …

… reported a role for IL-6 and IL-10 in monitoring COVID-19 patients. In particular, significantly
higher levels of IL-6 and IL-10 have been identified in severe COVID-19 patients than in the …

… , several drugs are under trials to control the cytokine storm. In this review, we … of cytokine
storms in COVID-19 patients. Hitherto, several promising candidates such as IL-1 and IL-6 …

… may experience a shorter duration of CRS than COVID-19 patients, the lack of a significant
difference in our findings might be related to the small sample sizes and different treatment …

… patients infected with COVID-19, we defined and identified eight patients (72.7%) with cytokine
release syndrome… increase of IL-6 in peripheral blood was the highest risk factor of CRSL. …